SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-012415
Filing Date
2021-01-20
Accepted
2021-01-20 16:10:53
Documents
14
Period of Report
2021-01-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d113105d8k.htm   iXBRL 8-K 30497
2 EX-99.1 d113105dex991.htm EX-99.1 6649
3 EX-99.2 d113105dex992.htm EX-99.2 312086
  Complete submission text file 0001193125-21-012415.txt   556347

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nvta-20210120.xsd EX-101.SCH 3066
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20210120_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20210120_pre.xml EX-101.PRE 10950
7 EXTRACTED XBRL INSTANCE DOCUMENT d113105d8k_htm.xml XML 3273
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 21538872
SIC: 8071 Services-Medical Laboratories